GCL
AEON icon

Glazer Capital LLC’s AEON Biopharma AEON Stock Holding History

Glazer Capital LLC’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-822
Closed -$613K – 169
2023
Q2 		$613K Sell
822
-2,269
-73% -$1.59M 0.04% 157
2023
Q1 		$2.26M Sell
3,091
-116
-4% -$84.2K 0.12% 156
2022
Q4 		$2.32M Buy
3,207
+71
+2% +$50.9K 0.06% 218
2022
Q3 		$2.22M Buy
3,136
+3
+0.1% +$2.13K 0.04% 307
2022
Q2 		$2.21M Buy
3,133
+169
+6% +$119K 0.06% 318
2022
Q1 		$2.09M Buy
2,964
+2,928
+8,133% +$2.05M 0.06% 250
2021
Q4 		$25K Hold
36
– – ﹤0.01% 769
2021
Q3 		$25K Sell
36
-2
-5% -$1.4K ﹤0.01% 855
2021
Q2 		$26K Buy
+38
New +$26.6K ﹤0.01% 883

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $648M AUM 11.62% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return